EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Beyond Prostaglandin E1: Management of Infants With Critical Congenital Heart Defects

Belinda Chan, Yogen Singh

NeoReviews · 2024

DOI: 10.1542/neo.25-12-e765 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift NeoReviews, 2024. Verfasst von Belinda Chan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Neonatology, University of Utah, Salt Lake City, UT. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Alprostadil. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Critical congenital heart defects (CHDs) are life-threatening cardiac lesions requiring cardiac surgery or transcatheter intervention or result in death within 28 days after birth. In infants with critical CHDs, delayed diagnosis and inappropriate management are associated with higher mortality and comorbidities. Antenatal anomaly screening and fetal echocardiography has improved the detection of fetal CHDs, which helps in perinatal management planning with multidisciplinary teams. Even with precision delivery planning, postnatal transition may affect each infant with CHDs differently depending on the variants and severity of the defect. Therefore, it is important to have a thorough understanding of the hemodynamic physiology in infants with a critical CHD during the transition from intrauterine to extrauterine life and alter management accordingly. This review summarizes the care of infants with critical CHDs in the immediate transition period with a focus on cases with distinctive physiology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Defects, CongenitalAlprostadilHumansInfant, NewbornFemale

Substanzen

Alprostadil

Autor:innen und Institutionen

  • Department of Pediatrics, Division of Neonatology, University of Utah, Salt Lake City, UT.
  • Department of Pediatrics, Division of Neonatology, University of California, Davis Health, Sacramento, CA.

Zitieren

APA

Chan, B., & Singh, Y. (2024). Beyond Prostaglandin E1: Management of Infants With Critical Congenital Heart Defects. NeoReviews. https://doi.org/10.1542/neo.25-12-e765

Vancouver

Chan B, Singh Y. Beyond Prostaglandin E1: Management of Infants With Critical Congenital Heart Defects. NeoReviews. 2024. doi:10.1542/neo.25-12-e765

BibTeX
@article{Chan2024,
  author = {Chan, Belinda and Singh, Yogen},
  title = {Beyond Prostaglandin E1: Management of Infants With Critical Congenital Heart Defects},
  journal = {NeoReviews},
  year = {2024},
  doi = {10.1542/neo.25-12-e765}
}
Kostenlos starten →